• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Structural signature of the MYPT1-PP1 interaction.MYPT1-PP1 相互作用的结构特征。
J Am Chem Soc. 2011 Jan 12;133(1):73-80. doi: 10.1021/ja107810r. Epub 2010 Dec 10.
2
Cell-Penetrating Peptide Based on Myosin Phosphatase Target Subunit Sequence Mediates Myosin Phosphatase Activity.基于肌球蛋白磷酸酶靶向亚基序列的细胞穿透肽介导肌球蛋白磷酸酶活性。
Biomolecules. 2025 May 12;15(5):705. doi: 10.3390/biom15050705.
3
Phosphorylated Peptide Derived from the Myosin Phosphatase Target Subunit Is a Novel Inhibitor of Protein Phosphatase-1.肌球蛋白磷酸酶靶蛋白亚基磷酸化肽是蛋白磷酸酶-1 的新型抑制剂。
Int J Mol Sci. 2023 Mar 1;24(5):4789. doi: 10.3390/ijms24054789.
4
The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1δ.肌球蛋白磷酸酶靶向蛋白(MYPT)家族:实现蛋白磷酸酶 1δ 催化亚基底物特异性的调节机制。
Arch Biochem Biophys. 2011 Jun 15;510(2):147-59. doi: 10.1016/j.abb.2011.01.018. Epub 2011 Feb 1.
5
Myosin phosphatase: Unexpected functions of a long-known enzyme.肌球蛋白磷酸酶:一种久为人知的酶的意外功能。
Biochim Biophys Acta Mol Cell Res. 2019 Jan;1866(1):2-15. doi: 10.1016/j.bbamcr.2018.07.023. Epub 2018 Aug 2.
6
A novel regulatory mechanism of myosin light chain phosphorylation via binding of 14-3-3 to myosin phosphatase.一种通过14-3-3与肌球蛋白磷酸酶结合实现肌球蛋白轻链磷酸化的新型调控机制。
Mol Biol Cell. 2008 Mar;19(3):1062-71. doi: 10.1091/mbc.e07-07-0668. Epub 2007 Dec 19.
7
TIMAP inhibits endothelial myosin light chain phosphatase by competing with MYPT1 for the catalytic protein phosphatase 1 subunit PP1cβ.TIMAP 通过与 MYPT1 竞争催化蛋白磷酸酶 1 亚基 PP1cβ 来抑制内皮肌球蛋白轻链磷酸酶。
J Biol Chem. 2019 Sep 6;294(36):13280-13291. doi: 10.1074/jbc.RA118.006075. Epub 2019 Jul 17.
8
Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits.磷蛋白抑制剂CPI-17的特异性取决于调节亚基对蛋白磷酸酶-1的变构调节。
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8888-93. doi: 10.1073/pnas.0307812101. Epub 2004 Jun 7.
9
Phosphorylation of MYPT1 by protein kinase C attenuates interaction with PP1 catalytic subunit and the 20 kDa light chain of myosin.蛋白激酶C介导的MYPT1磷酸化作用减弱了其与PP1催化亚基及肌球蛋白20 kDa轻链的相互作用。
FEBS Lett. 2000 Nov 3;484(2):113-7. doi: 10.1016/s0014-5793(00)02138-4.
10
Assembly of MYPT1 with protein phosphatase-1 in fibroblasts redirects localization and reorganizes the actin cytoskeleton.在成纤维细胞中,MYPT1与蛋白磷酸酶-1的组装会改变定位并重组肌动蛋白细胞骨架。
Cell Motil Cytoskeleton. 2005 Oct;62(2):100-9. doi: 10.1002/cm.20088.

引用本文的文献

1
Single-cell transcriptomics and tissue metabolomics uncover mechanisms underlying wooden breast disease in broilers.单细胞转录组学和组织代谢组学揭示了肉鸡木胸病的潜在机制。
Poult Sci. 2024 Dec;103(12):104433. doi: 10.1016/j.psj.2024.104433. Epub 2024 Oct 19.
2
Leishmania PNUTS discriminates between PP1 catalytic subunits through an RVxF-ΦΦ-F motif and polymorphisms in the PP1 C-tail and catalytic domain.利什曼原虫PNUTS通过RVxF-ΦΦ-F基序以及PP1 C末端和催化结构域中的多态性来区分PP1催化亚基。
J Biol Chem. 2023 Dec;299(12):105432. doi: 10.1016/j.jbc.2023.105432. Epub 2023 Nov 4.
3
Identification of PP1c-PPP1R12A Substrates Using Kinase-Catalyzed Biotinylation to Identify Phosphatase Substrates.利用激酶催化生物素化鉴定磷酸酶底物来鉴定PP1c-PPP1R12A底物。
ACS Omega. 2023 Sep 21;8(39):35628-35637. doi: 10.1021/acsomega.3c01944. eCollection 2023 Oct 3.
4
The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer.表观遗传修饰在卵巢癌中的新兴作用和治疗意义。
Front Endocrinol (Lausanne). 2022 May 10;13:863541. doi: 10.3389/fendo.2022.863541. eCollection 2022.
5
Identification of an α-MoRF in the Intrinsically Disordered Region of the Escargot Transcription Factor.在蜗牛转录因子的内在无序区域中鉴定出一个α-莫夫(α-MoRF)。
ACS Omega. 2020 Jul 17;5(29):18331-18341. doi: 10.1021/acsomega.0c02051. eCollection 2020 Jul 28.
6
The reduced activity of PP-1α under redox stress condition is a consequence of GSH-mediated transient disulfide formation.在氧化应激条件下,PP-1α 活性降低是 GSH 介导的瞬时二硫键形成的结果。
Sci Rep. 2018 Dec 7;8(1):17711. doi: 10.1038/s41598-018-36267-6.
7
Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer.表观遗传沉默肿瘤抑制因子 Par-4 促进复发性乳腺癌的化疗耐药性。
J Clin Invest. 2018 Oct 1;128(10):4413-4428. doi: 10.1172/JCI99481. Epub 2018 Aug 27.
8
Overexpression of Myosin Phosphatase Target Subunit 1 (MYPT1) Inhibits Tumor Progression and Metastasis of Gastric Cancer.肌球蛋白磷酸酶靶蛋白 1(MYPT1)过表达抑制胃癌的肿瘤进展和转移。
Med Sci Monit. 2018 Apr 24;24:2508-2517. doi: 10.12659/msm.906852.
9
Identification of PP1-Gadd34 substrates involved in the unfolded protein response using K-BIPS, a method for phosphatase substrate identification.使用K-BIPS(一种磷酸酶底物鉴定方法)鉴定参与未折叠蛋白反应的PP1-Gadd34底物。
Mol Omics. 2018 Apr 16;14(2):121-133. doi: 10.1039/c7mo00064b.
10
Expression of MYPT1, CPI-17 and MLC20 in ileum of neonatal mouse NEC model and its significance.MYPT1、CPI-17和MLC20在新生小鼠坏死性小肠结肠炎模型回肠中的表达及其意义
Exp Ther Med. 2017 Sep;14(3):2221-2227. doi: 10.3892/etm.2017.4783. Epub 2017 Jul 12.

本文引用的文献

1
Structural diversity in free and bound states of intrinsically disordered protein phosphatase 1 regulators.无规则蛋白磷酸酶 1 调节因子在自由态和结合态下的结构多样性。
Structure. 2010 Sep 8;18(9):1094-103. doi: 10.1016/j.str.2010.05.015.
2
The extended PP1 toolkit: designed to create specificity.扩展的 PP1 工具包:旨在提高特异性。
Trends Biochem Sci. 2010 Aug;35(8):450-8. doi: 10.1016/j.tibs.2010.03.002. Epub 2010 May 1.
3
Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sites.螺旋蛋白通过阻断底物结合位点来指导蛋白磷酸酶 1 的特异性。
Nat Struct Mol Biol. 2010 Apr;17(4):459-64. doi: 10.1038/nsmb.1786. Epub 2010 Mar 21.
4
Structure and disorder in an unfolded state under nondenaturing conditions from ensemble models consistent with a large number of experimental restraints.来自与大量实验约束条件一致的系综模型的非变性条件下未折叠状态的结构与无序性。
J Mol Biol. 2009 Aug 14;391(2):359-74. doi: 10.1016/j.jmb.2009.06.001. Epub 2009 Jun 6.
5
Docking motif-guided mapping of the interactome of protein phosphatase-1.基于对接基序引导的蛋白磷酸酶-1相互作用组图谱绘制
Chem Biol. 2009 Apr 24;16(4):365-71. doi: 10.1016/j.chembiol.2009.02.012.
6
Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: a novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors.与节球藻毒素-R和互隔交链孢酚结合的蛋白磷酸酶-1晶体结构:丝氨酸/苏氨酸磷酸酶抑制剂基于结构药物设计的新型支架
J Mol Biol. 2009 Jan 9;385(1):11-21. doi: 10.1016/j.jmb.2008.10.053. Epub 2008 Nov 1.
7
Detailed structural characterization of unbound protein phosphatase 1 inhibitors.未结合的蛋白磷酸酶1抑制剂的详细结构表征。
Biochemistry. 2008 Nov 25;47(47):12346-56. doi: 10.1021/bi801308y.
8
Calculation of residual dipolar couplings from disordered state ensembles using local alignment.使用局部比对从无序状态集合计算剩余偶极耦合。
J Am Chem Soc. 2008 Jun 25;130(25):7804-5. doi: 10.1021/ja802220c. Epub 2008 May 31.
9
NMR: prediction of molecular alignment from structure using the PALES software.核磁共振:使用PALES软件从结构预测分子排列。
Nat Protoc. 2008;3(4):679-90. doi: 10.1038/nprot.2008.36.
10
Myosin phosphatase target subunit: Many roles in cell function.肌球蛋白磷酸酶靶向亚基:在细胞功能中的多种作用。
Biochem Biophys Res Commun. 2008 Apr 25;369(1):149-56. doi: 10.1016/j.bbrc.2007.12.090. Epub 2007 Dec 26.

MYPT1-PP1 相互作用的结构特征。

Structural signature of the MYPT1-PP1 interaction.

机构信息

Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, Rhode Island 02903, USA.

出版信息

J Am Chem Soc. 2011 Jan 12;133(1):73-80. doi: 10.1021/ja107810r. Epub 2010 Dec 10.

DOI:10.1021/ja107810r
PMID:21142030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3016445/
Abstract

Muscle relaxation is triggered by the dephosphorylation of Ser19 in the myosin regulatory light chain. This reaction is catalyzed by the holoenzyme myosin phosphatase (MP), which includes the catalytic subunit protein phosphatase 1 (PP1) and the regulatory targeting subunit (MYPT). MYPT1 (myosin phosphatase targeting subunit 1) is responsible for both targeting the holoenzyme to subcellular compartments in the muscle and directing PP1 specificity toward myosin. To understand the molecular events leading to the MYPT1-PP1 holoenzyme formation, we used NMR spectroscopy to determine the structural and dynamic characteristics of unbound MYPT1. This allowed the conformations of MYPT1 in the free, unbound state to be directly compared to the PP1-bound state. Our results show that MYPT1(1-98) behaves like a two-domain protein in solution. The first 40 residues of MYPT1(1-98), the disordered region, are intrinsically disordered and highly dynamic, whereas residues 41-98, the folded ankyrin-repeat region, are well-structured and rigid. Furthermore, the integrated use of NMR and biophysical data enabled us to calculate an ensemble model for MYPT1(1-98). The most prominent structural feature of the MYPT1(1-98) ensemble is a 25% populated transient α-helix in the disordered region of MYPT1(1-98). This α-helix becomes fully populated when bound to PP1 and, as we show, likely plays a central role in the formation of the MYPT1-PP1 holoenzyme complex. Finally, this combined analysis shows that the structural and dynamic behaviors exhibited by MYPT1 for PP1 are distinct from those of any other previously analyzed PP1 regulatory protein. Collectively, these data enable us to present a new model of the molecular events that drive MYPT1-PP1 holoenzyme formation and demonstrate that there are structural differences in unbound PP1 regulators that have not been previously observed. Thus, this work adds significant insights to the currently limited data for molecular structures and dynamics of PP1 regulators.

摘要

肌松是由肌球蛋白调节轻链 Ser19 的去磷酸化触发的。该反应由全酶肌球蛋白磷酸酶 (MP) 催化,其中包括催化亚基蛋白磷酸酶 1 (PP1) 和调节靶向亚基 (MYPT)。MYPT1(肌球蛋白磷酸酶靶向亚基 1) 负责将全酶靶向肌肉中的亚细胞区室,并指导 PP1 特异性针对肌球蛋白。为了了解导致 MYPT1-PP1 全酶形成的分子事件,我们使用 NMR 光谱学来确定未结合的 MYPT1 的结构和动态特征。这使得可以直接比较 MYPT1 在游离、未结合状态下的构象与与 PP1 结合的状态。我们的结果表明,MYPT1(1-98)在溶液中表现为一种两域蛋白。MYPT1(1-98)的前 40 个残基,即无序区,是无规卷曲的,高度动态的,而残基 41-98,即折叠的锚蛋白重复区,是结构良好的刚性结构。此外,NMR 和生物物理数据的综合使用使我们能够为 MYPT1(1-98)计算一个整体模型。MYPT1(1-98)整体模型的最突出的结构特征是 MYPT1(1-98)无序区中 25%的瞬态 α-螺旋。当与 PP1 结合时,该 α-螺旋完全被占据,并且正如我们所示,它可能在 MYPT1-PP1 全酶复合物的形成中起核心作用。最后,这种综合分析表明,MYPT1 对 PP1 表现出的结构和动态行为与任何其他以前分析的 PP1 调节蛋白都不同。总的来说,这些数据使我们能够提出一个新的模型,用于驱动 MYPT1-PP1 全酶形成的分子事件,并证明在未结合的 PP1 调节蛋白中存在以前未观察到的结构差异。因此,这项工作为目前有限的 PP1 调节蛋白的分子结构和动力学数据提供了重要的见解。